Innovating Works

HPA

RISK - IR: Risk Stem Cells and Tissue Kinetics Ionising Radiation HEALTH PROTECTION AGENCY HPA participó en un FP7 The magnitude of cancer risk in humans exposed to low radiation doses (<100mSv) is uncertain and depends upon extrapolation of human populat...
Financiado
SLAM: Standardisation of laboratory analytical methods HEALTH PROTECTION AGENCY HPA participó en un FP7 SLAM is a project proposal for a supporting and coordinating activity with the objective of reviewing the needs for standardisation of CBRN...
Financiado
EVA: European Virus Archive HEALTH PROTECTION AGENCY HPA participó en un FP7 During the past 70 years or more, thousands of viruses have been isolated and partly characterised by experts working in different countries...
Financiado
OPTIMALVAC: Initiative on Optimizing Malaria Vaccine Lab Assays Evaluation HEALTH PROTECTION AGENCY HPA participó en un FP7 A broad-range of candidate malaria vaccines derived from diverse novel technologies have resulted from the multiple approaches being taken b...
Financiado
SOLO: Epidemiological Studies of Exposed Southern Urals Populations HEALTH PROTECTION AGENCY HPA participó en un FP7 This project aims to improve estimates of the risks of long-term health effects associated with protracted external and internal radiation e...
Financiado
ICEPURE: The impact of climatic and environmental factors on personal ultraviolet radiation exposure and huma... HEALTH PROTECTION AGENCY HPA participó en un FP7 We will determine the adverse and beneficial health effects of personal UVR exposure and their relationships with climatic and environmental...
Financiado
BIOVACSAFE: Biomarkers For Enhanced Vaccine Safety HEALTH PROTECTION AGENCY HPA participó en un FP7 BioVacSafe is a concise consortium of selected academic, public, and SME participants used to co-working in industry-led projects, organised...
Financiado
HAMLET: Human ModeL MATROSHKA for Radiation Exposure Determination of Astronauts HEALTH PROTECTION AGENCY HPA participó en un FP7 The European Space Agency’s project MATROSHKA (MTR), dedicated to determine the radiation load on astronauts in- and outside the Internation...
Financiado
TROCAR: Translational Research on Combating Antimicrobial Resistance HEALTH PROTECTION AGENCY HPA participó en un FP7 The health care systems of most European countries are based on a continuum from acute care hospitals, though other health care facilities t...
Financiado
DEVANI: Design of a vaccine to immunize neonates against GBS infections through a durable maternal immune re... HEALTH PROTECTION AGENCY HPA participó en un FP7 Direct vaccination cannot prevent diseases that affect neonates in the first days of life. Group B Streptococcus (GBS) is the major cause of...
Financiado
TENEB: Towards a European Network of Excellence in Biological Dosimetry HEALTH PROTECTION AGENCY HPA participó en un FP7 In recent years a number of accidents have occurred that show the necessity to be prepared for a possible large-scale radiological accident...
Financiado
PROCARDIO: Cardiovascular Risk from Exposure to Low dose and Low dose rate Ionizing Radiation HEALTH PROTECTION AGENCY HPA participó en un FP7 Epidemiological evidence has established a link between cardiovascular disease and exposure of the heart and major vessels to doses above 50...
Financiado
RENEB: Realizing the European Network in Biodosimetry HEALTH PROTECTION AGENCY HPA participó en un FP7 Creating a sustainable network in biological dosimetry that involves a large number of experienced laboratories throughout the EU will signi...
Financiado
ENETRAP-II: European Network for Education and Training in Radiation Protection II HEALTH PROTECTION AGENCY HPA participó en un FP7 As is the case with all nuclear expertise, there is a trend of a decreasing number of experts in radiation protection due to various reasons...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.